Author: MyHairline Editorial Team Editorial review: MyHairline medical content review. Named clinician reviewer pending verified reviewer relationship and crawlable bio. Last updated: May 2026
Educational use only. This article is not medical advice. The Myhairline.ai analyzer is an educational classification tool and does not diagnose, treat, or prescribe. Treatment decisions belong with a board-certified dermatologist or qualified clinician.
Last October, a guy named Brian in Scottsdale sent me a photo of his bathroom counter. Two boxes, side by side. A Theradome LH80 Pro ($895) and an iRestore Professional ($1,195). "I've been staring at these for three days," he wrote. "My wife thinks I've lost it. I just want to know which one actually works." Brian is 34, maybe Norwood III, and he'd already been on finasteride for a year with what he described as "okay but not great" results. He wanted to add a device. He did not want to waste a thousand dollars on a glorified bike helmet.
His question is the right one. And the honest answer is more interesting (and more frustrating) than most comparison sites make it seem.
The Real Difference Between These Two Devices
Both Theradome and iRestore are consumer low-level laser therapy (LLLT) helmets cleared by the FDA through the 510(k) pathway. That's important to understand upfront: 510(k) clearance means the FDA found each device "substantially equivalent" to a predicate device already on the market. It is not the same as the PMA (premarket approval) process used for new drugs like finasteride. The clearance bar is lower, and the evidence requirements are different.
Both devices sit in the 650 to 680 nanometer red light range, which is where the clinical literature on LLLT for hair loss has focused. Theradome's flagship LH80 Pro uses 80 proprietary laser diodes. iRestore's Professional model uses a combination of laser diodes and LEDs totaling 282 light sources, though the clinical significance of mixing LEDs with lasers is debated, and "more diodes" does not automatically mean better outcomes.
Here's the thing: neither company has published its own large, independent, randomized controlled trial in a peer-reviewed journal in the way finasteride or minoxidil have been studied. The device category as a whole leans on the 2014 Jimenez et al. trial in the American Journal of Clinical Dermatology, which demonstrated modest hair count improvements compared with sham devices. "Modest" is doing real work in that sentence. The effect sizes were smaller than those seen with FDA-approved medications, and the trial used a clinic-based protocol, not necessarily the exact consumer device sitting in your Amazon cart.
What the Clinical Evidence Actually Supports
Let's be blunt about the evidence hierarchy here.
The strongest trial data in non-surgical hair loss belongs to finasteride and minoxidil. The 1998 Kaufman et al. finasteride trials in the Journal of the American Academy of Dermatology and the 2002 Olsen et al. minoxidil trials in the same journal are the reference points. Both demonstrated significant effects versus placebo in stabilizing or modestly improving hair counts in men with androgenetic alopecia.
LLLT sits a tier below. The Jimenez et al. (2014) trial is legitimate, but the evidence base is thinner, the effect sizes more modest, and the replication less extensive. For PRP, the 2019 Journal of Dermatological Treatment meta-analysis pooled mixed-quality studies and found a small but statistically significant aggregate effect, though heterogeneity across studies was substantial.
So when you're comparing Theradome vs iRestore, you're comparing two devices in a category where the clinical evidence is real but not overwhelming. Neither device is snake oil. Neither device is finasteride. That's the boring truth, and it matters more than diode counts.
Price, Protocol, and the Stuff That Actually Varies
Where Theradome and iRestore genuinely differ is in the practical experience of using them.
Cost. The Theradome LH80 Pro retails around $895. The iRestore Professional runs about $1,195. The iRestore Essential (their lower-tier model) comes in closer to $695 but with fewer light sources. No ongoing subscription costs for either, which is a real advantage over monthly medication subscriptions.
Treatment time. Theradome recommends twice-weekly sessions of about 20 minutes. iRestore recommends every-other-day sessions of 25 minutes. Over a year, that adds up to a meaningful difference in how much time you spend wearing a plastic helmet on your couch.
Comfort and design. This sounds trivial until you're six months in and compliance is the main variable determining whether you see results. Theradome is lighter (fewer diodes, simpler build). iRestore Professional is bulkier but covers more scalp area. Both look vaguely ridiculous, which is relevant only if you live with people who will make fun of you. (They will.)
Warranty and return policy. Both companies offer return windows, though the specifics shift. Check current terms before purchasing. Theradome has historically offered a longer satisfaction guarantee.
None of these differences change the underlying biology. Red light at 650 to 680 nanometers hits your follicles whether it comes from a Theradome or an iRestore. The question is whether you'll actually use the device consistently for six to twelve months, because that's the minimum timeframe where any LLLT effect would become visible.
Why Most Comparison Articles Get This Wrong
I'll tell you exactly why most "Theradome vs iRestore" articles are useless. They're structured around affiliate commissions. The device with the better affiliate payout gets the "Editor's Pick" badge. The other device gets a vaguely lukewarm review. Neither article mentions that the entire device category has weaker evidence than a $9 bottle of generic minoxidil from CVS.
The dermatology literature, rooted in Hamilton's foundational 1951 classification in the Annals of the New York Academy of Sciences and Norwood's 1975 work in the Southern Medical Journal, tells us that androgenetic alopecia is progressive and pattern-specific. The right intervention depends on where you are on that progression, your tolerance for medication side effects, and what outcomes you actually consider success.
A Norwood II patient who can't tolerate finasteride and wants a non-pharmaceutical adjunct to topical minoxidil? LLLT is a reasonable addition. A Norwood V patient expecting a laser helmet alone to regrow a full head of hair? That patient is going to be disappointed, regardless of which brand they choose.
So Which One Should Brian Buy?
I told Brian the honest answer: for his situation (Norwood III, already on finasteride, looking for an adjunct), either device is a defensible choice. The Theradome was cheaper and required less time per week. The iRestore covered more area and might feel like "more" was happening, even if the clinical significance of that difference is unclear.
What I actually told him to do first was talk to his dermatologist about adding topical minoxidil, which has decades of stronger evidence and costs a fraction of either device. If he was already doing that, then sure, pick the helmet that fits your budget and your schedule.
He went with the Theradome. Six months later he told me he thought it was "maybe helping a little." Which is, honestly, about what the literature would predict.
The Device vs. Medication Reality Check
If you came here searching "theradome vs irestore" and you're not already using minoxidil or finasteride (or both), I'd respectfully suggest you're optimizing the wrong variable. It's like debating which premium tire to put on a car that doesn't have an engine.
For androgenetic alopecia, the medications have substantially more replicated trial evidence than any device. Low-level laser therapy has trial-level support, but smaller effect sizes. The most defensible treatment strategy starts with the well-evidenced interventions and adds devices as adjuncts, not replacements.
That said, some people genuinely cannot or will not take finasteride. Some people experience side effects with minoxidil. For those patients, LLLT represents a non-pharmaceutical option with some evidentiary support and a favorable safety profile. That's a legitimate use case, just not the one most comparison articles are written for.
Common Questions
Does Theradome or iRestore have stronger clinical evidence behind its specific device? Neither company has published a large, independent, peer-reviewed randomized controlled trial specific to its consumer device. Both rely on the broader LLLT evidence base, particularly the Jimenez et al. (2014) trial in the American Journal of Clinical Dermatology.
Is one device FDA-approved? Both are FDA-cleared via the 510(k) pathway, which demonstrates substantial equivalence to a predicate device. Neither has gone through the more rigorous PMA process used for new drugs.
Can I use a laser helmet instead of minoxidil or finasteride? You can, but the evidence base is substantially weaker. For androgenetic alopecia, finasteride and minoxidil remain the first-line treatments with the strongest trial data. LLLT devices are best understood as adjuncts.
Does the Myhairline.ai analyzer diagnose hair loss? No. The analyzer is an educational classification tool. It does not diagnose, treat, or prescribe. A clinical diagnosis of any hair loss condition requires examination by a board-certified dermatologist.
Are the treatment claims in this article guarantees? No. Every treatment discussed has documented variability in outcome across patients. No medication, procedure, or device guarantees regrowth, and no responsible clinician or article should claim otherwise.
Does "more diodes" mean better results? Not necessarily. Total energy delivered to the scalp matters, but so do wavelength, treatment duration, and adherence. A device with fewer diodes used consistently may outperform a device with more diodes used sporadically.
How long do I need to use a laser helmet before seeing results? Most protocols and the limited trial data suggest a minimum of six months of consistent use before evaluating results. Twelve months is a more realistic assessment window.
Continue Reading
This article is part of the Comparisons & Decision-Making cluster on Myhairline.ai. The pillar overview is The Norwood Scale: Complete Guide to Male Pattern Hair Loss Stages, and the cluster hub is Comparisons & Decision-Making Cluster Hub.
Within this cluster:
- Keeps Vs Hims: a focused reference on keeps vs hims.
- Capillus Vs Irestore: a focused reference on capillus vs irestore.
- Him Vs Keeps: a focused reference on him vs keeps.
Related from other clusters:
- Finasteride Hims: Complete Guide: a focused reference on finasteride hims. (from the Non-Surgical Treatments cluster).
- Turkey Hair Transplant Cost - Real Numbers: a focused reference on turkey hair transplant cost. (from the Hair Transplant Cost & Process cluster).
Key References
Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578-589.
Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2002;47(3):377-385.
Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss. American Journal of Clinical Dermatology. 2014;15(2):115-127.
Hamilton JB. Patterned loss of hair in man: types and incidence. Annals of the New York Academy of Sciences. 1951;53(3):708-728.
Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975;68(11):1359-1365.